Anacor Pharma posts psoriasis study results NECN (AP) — Anacor Pharmaceuticals Inc. is reporting affirmative results from a mid-stage trial of a drug candidate designed to delicacy the skin condition disease of the skin . Anacor said Mon that the drug ablated psoriasis plaques by xxvi percent after six weeks of the ... Anacor Pharmaceuticals Inc Announces affirmative Preliminary Results From state of matter ... BioMedReports (subscription) Anacor Pharmaceuticals Announces Positive explorative Results from Phase 2b ... MarketWatch (press release) all 42 news articles » Link To Article
No comments:
Post a Comment